Interesting new therapeutic in trials for Covid ... - MPN Voice

MPN Voice

10,784 members14,980 posts

Interesting new therapeutic in trials for Covid and AML

Paul123456 profile image
4 Replies

Company appear remarkably confident that will help with Covid, 80% chance of success according to press article this morning. Targets AXL mutation

bergenbio.com/bergenbios-be...

Written by
Paul123456 profile image
Paul123456
To view profiles and participate in discussions please or .
Read more about...
4 Replies
Paul123456 profile image
Paul123456

bergenbio.com/wp-content/up...

Re AML trial

Jazzyb50 profile image
Jazzyb50

Interesting thanks Paul. Let's hope it helps.

Paul123456 profile image
Paul123456

thelancet.com/journals/ecli...

Another interesting crossover drug. Adam Mead reckons a front runner for combating Covid cytokine storm

Dovme profile image
Dovme

A report on German news last night stated that Braunschweig scientists have been able to detect antibodies that prevent the virus from entering cells when researching the novel corona virus. "This is clearly a breakthrough that shows that we are on the right track for the development of a drug against Covid-19," They announced!

They are hoping to have a treatment available by autumn

Here is the link it’s in German but google translate is a marvelous thing

fr.de/wissen/coronavirus-br...

Not what you're looking for?

You may also like...

NEW HOPE FOR AML...

Post by MPN-MATE Admin » Wed Sep 25, 2019 2:05 am Hey everyone... :-) This article is a tad tough...

ET and Covid complications

Has anyone's doctor specifically assessed their risk of Covid complications for a person with ET?...

Email received: New Treatments for Covid.

Hi everyone, I have just received an Email today from NHS informing me that I will be having...

Covid and paxlovid

Hi all, I just wanted to share my experience with Paxlovid Covid medication. Having PV and low...

Covid Booster in Northern Ireland

Hi Everyone, I normally get a letter asking me to come and get my Covid Booster from the...